Inflammation and rate of cognitive change in high-functioning older adults.

BACKGROUND Inflammatory proteins including interleukin-6 (IL-6) and C-reactive protein (CRP) have been associated with incident cognitive impairment, but little research has addressed their effects on the rate of cognitive change, and findings are mixed. The purpose of this study was to examine the relationship between serum levels of IL-6 and CRP and the rate of cognitive change across a range of cognitive domains in a sample of healthy older persons. METHODS Growth curve analysis was performed on data from the MacArthur Study of Successful Aging, a longitudinal cohort study of high-functioning older adults aged 70-79 years at baseline in 1988 and reinterviewed in 1991 and 1995 (N = 851). Individual growth curve parameters were derived from baseline and follow-up performance in abstraction, language, spatial ability, verbal recall, spatial recognition, and global cognitive function based on age, IL-6, CRP, and covariates. RESULTS Cross-sectionally, there is a generally linear negative relationship between inflammation and cognition, such that higher levels of inflammation are associated with lower levels of baseline cognitive function. After controlling for potential confounders, there was no effect of inflammation on baseline cognitive function or the rate of longitudinal cognitive change. However, persons in the top tertile on IL-6 were at an increased risk of incident declines on the Short Portable Mental Status Questionnaire (SPMSQ). CONCLUSIONS Although high levels of inflammation are associated with incident cognitive impairment, these results do not generalize to the full range of cognitive changes, where the role of inflammation appears to be marginal.

[1]  T. Strandberg,et al.  Predictors of cognitive decline and mortality of aged people over a 10-year period. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  M. Albert,et al.  Cognitive performance in a high-functioning community-dwelling elderly population. , 1993, Journal of gerontology.

[3]  H. Steinbusch,et al.  Combination of serum markers related to several mechanisms in Alzheimer’s disease , 2003, Neurobiology of Aging.

[4]  A. Hofman,et al.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.

[5]  Joshua Chodosh,et al.  Predicting Cognitive Impairment in High‐Functioning Community‐Dwelling Older Persons: MacArthur Studies of Successful Aging , 2002, Journal of the American Geriatrics Society.

[6]  E. Kaplan,et al.  The Boston naming test , 2001 .

[7]  H. Christensen,et al.  Education, Activity, Health, Blood Pressure and Apolipoprotein E as Predictors of Cognitive Change in Old Age: A Review , 2000, Gerontology.

[8]  M. Albert,et al.  Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. , 1986, Archives of neurology.

[9]  J W Rowe,et al.  Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging , 2002, Neurology.

[10]  Luigi Ferrucci,et al.  Serum IL‐6 Level and the Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.

[11]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[12]  E. Mariani,et al.  Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  Judith D. Singer,et al.  Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models , 1998 .

[14]  Interleukin-6 and risk of cognitive decline , 2002 .

[15]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[16]  C. Caspersen,et al.  A survey for assessing physical activity among older adults. , 1993, Medicine and science in sports and exercise.

[17]  R. Mangiafico,et al.  Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. , 2006, Age and ageing.

[18]  L. Kurlowicz,et al.  The Mini Mental State Examination (MMSE). , 1999, Director.

[19]  E. Pfeiffer A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients † , 1975, Journal of the American Geriatrics Society.

[20]  J. Smit,et al.  Serum inflammatory proteins and cognitive decline in older persons , 2005, Neurology.

[21]  R. Sacco,et al.  Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. , 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[22]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[23]  M. Albert,et al.  High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. , 1993, Journal of clinical epidemiology.

[24]  H. Steinbusch,et al.  Inflammation markers in relation to cognition in a healthy aging population , 2003, Journal of Neuroimmunology.

[25]  S. Rubin,et al.  Inflammatory markers and cognition in well-functioning African-American and white elders , 2003, Neurology.